comparemela.com

Dennis Dlugos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nonmotor seizures goes undetected in pediatric emergency departments

Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Bexicaserin achieved a median seizure reduction of 53.3% in countable motor seizures compared to 20.8% in the placebo group across the DEE study population A median seizure reduction of 72.1% in.

Longboard Pharmaceuticals (LBPH) Reports Positive Topline Data from the PACIFIC Study

Longboard Pharmaceuticals (LBPH) Reports Positive Topline Data from the PACIFIC Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.